메뉴 건너뛰기




Volumn 19, Issue 8, 2008, Pages 1371-1378

UFT (tegafur-uracil) in rectal cancer

Author keywords

Chemoradiotherapy; Oral fluoropyrimidines; Rectal cancer; Tegafur uracil; UFT

Indexed keywords

CAPECITABINE; CARBOPLATIN; DOCETAXEL; FLUOROURACIL; FOLINIC ACID; IRINOTECAN; MITOMYCIN C; OXALIPLATIN; UFT;

EID: 48749124860     PISSN: 09237534     EISSN: 15698041     Source Type: Journal    
DOI: 10.1093/annonc/mdn067     Document Type: Review
Times cited : (21)

References (63)
  • 1
    • 33847638137 scopus 로고    scopus 로고
    • Estimates of the cancer incidence and mortality in Europe in 2006
    • Ferlay J, Autier P, Boniol M et al. Estimates of the cancer incidence and mortality in Europe in 2006. Ann Oncol 2007; 18: 581-592.
    • (2007) Ann Oncol , vol.18 , pp. 581-592
    • Ferlay, J.1    Autier, P.2    Boniol, M.3
  • 2
    • 21044443320 scopus 로고    scopus 로고
    • ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer
    • Tveit K. ESMO Guidelines Task Force. ESMO minimum clinical recommendations for diagnosis, treatment and follow-up of rectal cancer. Ann Oncol 2005; 16 (Suppl 1): I20-i21.
    • (2005) Ann Oncol , vol.16 , Issue.SUPPL. 1
    • Tveit, K.1
  • 3
    • 48749107348 scopus 로고    scopus 로고
    • European Network of Cancer Registries. EUROCIM Version 4.0. European Incidence Database V2.2. (1999). Lyon, France: International Agency for Research on Cancer 2001.
    • European Network of Cancer Registries. EUROCIM Version 4.0. European Incidence Database V2.2. (1999). Lyon, France: International Agency for Research on Cancer 2001.
  • 5
    • 6044226542 scopus 로고    scopus 로고
    • Preoperative versus postoperative chemoradiotherapy for rectal cancer
    • Sauer R, Becker H, Hohenberger W et al. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med 2004; 351: 1731-1740.
    • (2004) N Engl J Med , vol.351 , pp. 1731-1740
    • Sauer, R.1    Becker, H.2    Hohenberger, W.3
  • 6
    • 33748676449 scopus 로고    scopus 로고
    • Chemotherapy with preoperative radiotherapy in rectal cancer
    • Bosset JF, Collette L, Calais G et al. Chemotherapy with preoperative radiotherapy in rectal cancer. N Engl J Med 2006; 355: 1114-1123.
    • (2006) N Engl J Med , vol.355 , pp. 1114-1123
    • Bosset, J.F.1    Collette, L.2    Calais, G.3
  • 7
    • 48749107599 scopus 로고    scopus 로고
    • National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Rectal Cancer. V1,2008. http://www.nccn.org/professionals/ physician_gls/PDF/rectal.pdf (12 February 2008, date last accessed).
    • National Comprehensive Cancer Network. Clinical Practice Guidelines in Oncology. Rectal Cancer. V1,2008. http://www.nccn.org/professionals/ physician_gls/PDF/rectal.pdf (12 February 2008, date last accessed).
  • 8
    • 33747067709 scopus 로고    scopus 로고
    • Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144
    • Smalley SR, Benedetti JK, Williamson SK et al. Phase III trial of fluorouracil-based chemotherapy regimens plus radiotherapy in postoperative adjuvant rectal cancer: GI INT 0144. J Clin Oncol 2006; 24: 3542-3547.
    • (2006) J Clin Oncol , vol.24 , pp. 3542-3547
    • Smalley, S.R.1    Benedetti, J.K.2    Williamson, S.K.3
  • 9
    • 0031022803 scopus 로고    scopus 로고
    • Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer
    • Webb A, Cunningham D, Scarffe JH et al. Randomized trial comparing epirubicin, cisplatin, and fluorouracil versus fluorouracil, doxorubicin, and methotrexate in advanced esophagogastric cancer. J Clin Oncol 1997; 15: 261-267.
    • (1997) J Clin Oncol , vol.15 , pp. 261-267
    • Webb, A.1    Cunningham, D.2    Scarffe, J.H.3
  • 10
    • 0037090686 scopus 로고    scopus 로고
    • Prospective randomized trial comparing mitomycin, cisolatin and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin and PVI 5-FU in advanced esophagogastric cancer
    • Ross P, Nicolson M, Cunningham D et al. Prospective randomized trial comparing mitomycin, cisolatin and protracted venous-infusion fluorouracil (PVI 5-FU) with epirubicin, cisplatin and PVI 5-FU in advanced esophagogastric cancer. J Clin Oncol 2002; 20: 1996-2004.
    • (2002) J Clin Oncol , vol.20 , pp. 1996-2004
    • Ross, P.1    Nicolson, M.2    Cunningham, D.3
  • 11
    • 0031691506 scopus 로고    scopus 로고
    • Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1- (2′-tetrahydrofuryl -5-fluorouracil
    • Ho DH, Pazdur R, Covington W et al. Comparison of 5-fluorouracil pharmacokinetics in patients receiving continuous 5-fluorouracil infusion and oral uracil plus N1- (2′-tetrahydrofuryl -5-fluorouracil. Clin Cancer Res 1998; 4: 2085-2088.
    • (1998) Clin Cancer Res , vol.4 , pp. 2085-2088
    • Ho, D.H.1    Pazdur, R.2    Covington, W.3
  • 12
    • 0036731818 scopus 로고    scopus 로고
    • Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patents with previously untreated metastatic colorectal cancer
    • Douillard JY, Hoff PM, Skillings JR et al. Multicenter phase III study of uracil/tegafur and oral leucovorin versus fluorouracil and leucovorin in patents with previously untreated metastatic colorectal cancer. J Clin Oncol 2002; 20: 3605-3616.
    • (2002) J Clin Oncol , vol.20 , pp. 3605-3616
    • Douillard, J.Y.1    Hoff, P.M.2    Skillings, J.R.3
  • 13
    • 0036727089 scopus 로고    scopus 로고
    • Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer
    • Carmichael J, Popiela T, Radstone D et al. Randomized comparative study of tegafur/uracil and oral leucovorin versus parenteral fluorouracil and leucovorin in patients with previously untreated metastatic colorectal cancer. J Clin Oncol 2002; 20: 3617-3627.
    • (2002) J Clin Oncol , vol.20 , pp. 3617-3627
    • Carmichael, J.1    Popiela, T.2    Radstone, D.3
  • 14
    • 0037231279 scopus 로고    scopus 로고
    • Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma
    • Taguchi T, Ikeda Y, Mikami Y et al. Combined radiotherapy and chemotherapy with carboplatin and UFT for head and neck squamous cell carcinoma. Anticancer Res 2003; 23(1B): 713-717.
    • (2003) Anticancer Res , vol.23 , Issue.1 B , pp. 713-717
    • Taguchi, T.1    Ikeda, Y.2    Mikami, Y.3
  • 15
    • 6544295384 scopus 로고    scopus 로고
    • UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer
    • Ichinose Y, Yano T, Asoh H et al. UFT plus cisplatin with concurrent radiotherapy for locally advanced non-small-cell lung cancer. Oncology (Huntingt) 1999; 13 (7 Suppl 3): 98-101.
    • (1999) Oncology (Huntingt) , vol.13 , Issue.7 SUPPL. 3 , pp. 98-101
    • Ichinose, Y.1    Yano, T.2    Asoh, H.3
  • 16
    • 1542603282 scopus 로고    scopus 로고
    • Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer
    • Byström P, Frödin JE, Berglund Å et al. Phase I study of UFT plus leucovorin with radiotherapy in patients with inextirpable non-rectal gastrointestinal cancer. Radiother OnGol 2004; 70: 171-175.
    • (2004) Radiother OnGol , vol.70 , pp. 171-175
    • Byström, P.1    Frödin, J.E.2    Berglund, A.3
  • 17
    • 0036235128 scopus 로고    scopus 로고
    • First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin
    • Cassidy J, Twelves C, Van Cutsem E et al. First-line oral capecitabine therapy in metastatic colorectal cancer: A favorable safety profile compared with intravenous 5-fluorouracil/leucovorin. Ann Oncol 2002; 13: 566-575.
    • (2002) Ann Oncol , vol.13 , pp. 566-575
    • Cassidy, J.1    Twelves, C.2    Van Cutsem, E.3
  • 18
    • 7344243730 scopus 로고    scopus 로고
    • Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: A Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study
    • Aranda E, Diaz-Rubio E, Cervantes A et al. Randomized trial comparing monthly low-dose leucovorin and fluorouracil bolus with weekly high-dose 48-hour continuous-infusion fluorouracil for advanced colorectal cancer: a Spanish Cooperative Group for Gastrointestinal Tumor Therapy (TTD) study. Ann Oncol 1998; 9: 727-731.
    • (1998) Ann Oncol , vol.9 , pp. 727-731
    • Aranda, E.1    Diaz-Rubio, E.2    Cervantes, A.3
  • 19
    • 0031017851 scopus 로고    scopus 로고
    • Patient preferences for oral versus intravenous palliative chemotherapy
    • Liu B, Franssen E, Fitch MI, Warner E. Patient preferences for oral versus intravenous palliative chemotherapy. J Clin Oncol 1997; 15: 110-115.
    • (1997) J Clin Oncol , vol.15 , pp. 110-115
    • Liu, B.1    Franssen, E.2    Fitch, M.I.3    Warner, E.4
  • 20
    • 0036159485 scopus 로고    scopus 로고
    • Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectall cancer
    • Borner MM, Schoffski P, de Wit R et al. Patient preference and pharmacokinetics of oral modulated UFT versus intravenous fluorouracil and leucovorin: A randomised crossover trial in advanced colorectall cancer. Eur J Cancer 2002; 38: 349-358.
    • (2002) Eur J Cancer , vol.38 , pp. 349-358
    • Borner, M.M.1    Schoffski, P.2    de Wit, R.3
  • 21
    • 33750179595 scopus 로고    scopus 로고
    • Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer
    • Pfeiffer P, Mortensen JP, Bjerregaard B et al. Patient preference for oral or intravenous chemotherapy: A randomised cross-over trial comparing capecitabine and Nordic fluorouracil/leucovorin in patients with colorectal cancer. Eur J Cancer 2006; 42: 2738-2743.
    • (2006) Eur J Cancer , vol.42 , pp. 2738-2743
    • Pfeiffer, P.1    Mortensen, J.P.2    Bjerregaard, B.3
  • 22
    • 48749096430 scopus 로고    scopus 로고
    • QoL and resource use analysis of tegafururacil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study
    • Abstr 3631
    • Sizer B, Makris A, Barone C et al. QoL and resource use analysis of tegafururacil/LV or 5-FU/LV in first-line metastatic colorectal cancer (mCRC): Final results of a multicenter phase II study. J Clin Oncol 2006; 24 (Suppl): (Abstr 3631).
    • (2006) J Clin Oncol , vol.24 , Issue.SUPPL.
    • Sizer, B.1    Makris, A.2    Barone, C.3
  • 23
    • 0034667864 scopus 로고    scopus 로고
    • Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer
    • Hoff PM, Janjan N, Saad ED et al. Phase I study of preoperative oral uracil and tegafur plus leucovorin and radiation therapy in rectal cancer. J Clin Oncol 2000; 18: 3529-3534.
    • (2000) J Clin Oncol , vol.18 , pp. 3529-3534
    • Hoff, P.M.1    Janjan, N.2    Saad, E.D.3
  • 24
    • 5044220053 scopus 로고    scopus 로고
    • A phase I study of oral UFT given concomitantly with standard preoperabve radiotherapy for rectal cancer
    • Pfeffer MR, Kundel Y, Zehavi M et al. A phase I study of oral UFT given concomitantly with standard preoperabve radiotherapy for rectal cancer. Isr Med Assoc J 2004; 6: 595-598.
    • (2004) Isr Med Assoc J , vol.6 , pp. 595-598
    • Pfeffer, M.R.1    Kundel, Y.2    Zehavi, M.3
  • 25
    • 20044396718 scopus 로고    scopus 로고
    • Pre-operabve chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer
    • Wang LW, Yang SH, Lin JK et al. Pre-operabve chemoradiotherapy with oral tegafur-uracil and leucovorin for rectal cancer. J Surg Oncol 2005; 89: 256-263.
    • (2005) J Surg Oncol , vol.89 , pp. 256-263
    • Wang, L.W.1    Yang, S.H.2    Lin, J.K.3
  • 26
    • 67649614659 scopus 로고    scopus 로고
    • Preoperatve radiaton and daily oral UFT in combinabon with leucovorin in locally advanced rectal (LARC) cancer
    • Abstr 3676
    • Gamelin E, Cellier P, Leduc B et al. Preoperatve radiaton and daily oral UFT in combinabon with leucovorin in locally advanced rectal (LARC) cancer. J Clin Oncol 2004; 22 (14 Suppl): (Abstr 3676).
    • (2004) J Clin Oncol , vol.22 , Issue.14 SUPPL.
    • Gamelin, E.1    Cellier, P.2    Leduc, B.3
  • 27
    • 4143132330 scopus 로고    scopus 로고
    • Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up
    • Fernandez-Martos C, Aparicio J, Bosch C et al. Preoperative uracil, tegafur, and concomitant radiotherapy in operable rectal cancer: A phase II multicenter study with 3 years' follow-up. J Clin Oncol 2004; 22: 3016-3022.
    • (2004) J Clin Oncol , vol.22 , pp. 3016-3022
    • Fernandez-Martos, C.1    Aparicio, J.2    Bosch, C.3
  • 28
    • 0035985283 scopus 로고    scopus 로고
    • Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy
    • Feliu J, Calvilio J, Escribano A et al. Neoadjuvant therapy of rectal carcinoma with UFT-leucovorin plus radiotherapy. Ann Oncol 2002; 13: 730-736.
    • (2002) Ann Oncol , vol.13 , pp. 730-736
    • Feliu, J.1    Calvilio, J.2    Escribano, A.3
  • 29
    • 0029563823 scopus 로고
    • Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study
    • Gonzalez-Baron M, Feliu J, de la Gandara I et al. Efficacy of oral tegafur modulation by uracil and leucovorin in advanced colorectal cancer. A phase II study. Eur J Cancer 1995; 31A: 2215-2219.
    • (1995) Eur J Cancer , vol.31 A , pp. 2215-2219
    • Gonzalez-Baron, M.1    Feliu, J.2    de la Gandara, I.3
  • 30
    • 34547764967 scopus 로고    scopus 로고
    • A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer
    • Kundel Y, Brenner B, Symon Z et al. A phase II study of oral UFT and leucovorin concurrently with pelvic irradiation as neoadjuvant chemoradiation for rectal cancer. Anticancer Res 2007; 27: 2877-2880.
    • (2007) Anticancer Res , vol.27 , pp. 2877-2880
    • Kundel, Y.1    Brenner, B.2    Symon, Z.3
  • 31
    • 37049017365 scopus 로고    scopus 로고
    • Preoperative chemoradiotherapy for rectal cancer: Randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin
    • de la Torre A, García-Berrocal MI, Arias F et al. Preoperative chemoradiotherapy for rectal cancer: Randomized trial comparing oral uracil and tegafur and oral leucovorin vs. intravenous 5-fluorouracil and leucovorin. Int J Radiat Oncol Biol Phys 2008; 70: 102-110.
    • (2008) Int J Radiat Oncol Biol Phys , vol.70 , pp. 102-110
    • de la Torre, A.1    García-Berrocal, M.I.2    Arias, F.3
  • 32
    • 0037086328 scopus 로고    scopus 로고
    • Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule
    • Cividalli A, Ceciarelli F, Livdi E et al. Radiosensitization by oxaliplatin in a mouse adenocarcinoma: Influence of treatment schedule. Int J Radiat Oncol Biol Phys 2002; 52: 1092-1098.
    • (2002) Int J Radiat Oncol Biol Phys , vol.52 , pp. 1092-1098
    • Cividalli, A.1    Ceciarelli, F.2    Livdi, E.3
  • 33
    • 21344435197 scopus 로고    scopus 로고
    • A phase I study of uracil/tegafur (UFT) and oral leucovorin (LV) + weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC)
    • Abstr 3637
    • Aschele C, Vitali ML, Binda GA. A phase I study of uracil/tegafur (UFT) and oral leucovorin (LV) + weekly oxaliplatin (OXA) and preoperative radiotherapy (RT) in locally advanced rectal cancer (LARC). J Clin Oncol 2004; 22 (14 Suppl): (Abstr 3637).
    • (2004) J Clin Oncol , vol.22 , Issue.14 SUPPL.
    • Aschele, C.1    Vitali, M.L.2    Binda, G.A.3
  • 34
    • 48749091738 scopus 로고    scopus 로고
    • Oxaliplatn, uracil/ tegafur (UFT) and radiotherapy in operable rectal cancer. Preliminary results of a multicenter phase II study
    • Abstr 3648
    • Fernandez-Martos C, Bosch C, Aparicio J et al. Oxaliplatn, uracil/ tegafur (UFT) and radiotherapy in operable rectal cancer. Preliminary results of a multicenter phase II study. J Clin Oncol 2005; 23 (16 Suppl): (Abstr 3648).
    • (2005) J Clin Oncol , vol.23 , Issue.16 SUPPL.
    • Fernandez-Martos, C.1    Bosch, C.2    Aparicio, J.3
  • 35
    • 48749088052 scopus 로고    scopus 로고
    • Preoperatve radiation with uracil/tegafur (UFT) and mitomycin C (MMC) in locally advanced rectal cancer
    • Abstr 13512
    • Gemici C, Mayadagli A, Salepci T et al. Preoperatve radiation with uracil/tegafur (UFT) and mitomycin C (MMC) in locally advanced rectal cancer. J Clin Oncol 2006; 24 (18 Suppl): (Abstr 13512).
    • (2006) J Clin Oncol , vol.24 , Issue.18 SUPPL.
    • Gemici, C.1    Mayadagli, A.2    Salepci, T.3
  • 36
    • 33845430414 scopus 로고    scopus 로고
    • Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer
    • Yasui M, Ikeda M, Sekimoto M et al. Preliminary results of phase I trial of oral uracil/tegafur (UFT), leucovorin plus irinotecan and radiation therapy for patients with locally recurrent rectal cancer, World J Surg Oncol 2006; 4: 83.
    • (2006) World J Surg Oncol , vol.4 , pp. 83
    • Yasui, M.1    Ikeda, M.2    Sekimoto, M.3
  • 37
    • 0032986274 scopus 로고    scopus 로고
    • Indicatons for and results of combined modality treatment of colorectal cancer
    • Gunderson LL. Indicatons for and results of combined modality treatment of colorectal cancer. Acta Oncol 1999; 38: 7-21.
    • (1999) Acta Oncol , vol.38 , pp. 7-21
    • Gunderson, L.L.1
  • 38
    • 0028692706 scopus 로고
    • Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer
    • Sanchiz F, Milla A. Tegafur-uracil (UFT) plus folinic acid in advanced rectal cancer. Jpn J Clin Oncol 1994; 24: 322-326.
    • (1994) Jpn J Clin Oncol , vol.24 , pp. 322-326
    • Sanchiz, F.1    Milla, A.2
  • 39
    • 12244271447 scopus 로고    scopus 로고
    • Phase I study of oral uracil and tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer
    • Schiebe ME, Reese T, Wenz F et al. Phase I study of oral uracil and tegafur plus leucovorin and pelvic radiation in patients with recurrent rectal cancer. Anticancer Drugs 2002; 13: 1005-1009.
    • (2002) Anticancer Drugs , vol.13 , pp. 1005-1009
    • Schiebe, M.E.1    Reese, T.2    Wenz, F.3
  • 40
    • 21344446775 scopus 로고    scopus 로고
    • High-dose radiotherapy and concurrent UFT plus I-leucovorin in locally advanced rectal cancer: A phase I trial
    • Pfeiffer P. High-dose radiotherapy and concurrent UFT plus I-leucovorin in locally advanced rectal cancer: A phase I trial. Acta Oncol 2005; 44: 224-229.
    • (2005) Acta Oncol , vol.44 , pp. 224-229
    • Pfeiffer, P.1
  • 41
    • 48749113857 scopus 로고    scopus 로고
    • A phase II trial of high-dose radiotherapy (60 Gy) and UFT/LV in patents with advanced rectal cancer (LARC): Long-term results
    • Abstr 3590
    • Ovortrup C, Jakobsen A, Hansen F et al. A phase II trial of high-dose radiotherapy (60 Gy) and UFT/LV in patents with advanced rectal cancer (LARC): Long-term results. J Clin Oncol 2004; 22 (14 Suppl): (Abstr 3590).
    • (2004) J Clin Oncol , vol.22 , Issue.14 SUPPL.
    • Ovortrup, C.1    Jakobsen, A.2    Hansen, F.3
  • 42
    • 0032850210 scopus 로고    scopus 로고
    • Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer
    • de la Torre A, Ramos S, Valcarcel FJ et al. Phase II study of radiochemotherapy with UFT and low-dose oral leucovorin in patients with unresectable rectal cancer. Int J Radiat Oncol Biol Phys 1999; 45: 629-634.
    • (1999) Int J Radiat Oncol Biol Phys , vol.45 , pp. 629-634
    • de la Torre, A.1    Ramos, S.2    Valcarcel, F.J.3
  • 43
    • 20044390067 scopus 로고    scopus 로고
    • Practice parameters for the management of rectal cancer (revised)
    • Tjandra JJ, Kilkenny JW, Buie WD et al. Practice parameters for the management of rectal cancer (revised). Dis Colon Rectum 2005; 48: 411-423.
    • (2005) Dis Colon Rectum , vol.48 , pp. 411-423
    • Tjandra, J.J.1    Kilkenny, J.W.2    Buie, W.D.3
  • 44
    • 0021792174 scopus 로고
    • Prolongation at the disease-free survival in surgically treated rectal cancer
    • Gastrointestinal Tumor Study Group
    • Gastrointestinal Tumor Study Group. Prolongation at the disease-free survival in surgically treated rectal cancer. N Engl J Med 1985; 312: 1465-1472.
    • (1985) N Engl J Med , vol.312 , pp. 1465-1472
  • 45
    • 0026071185 scopus 로고
    • Effective surgical adjuvant therapy for high-risk rectal carcinoma
    • Krook JE, Moertel CG, Gunderson LL et al. Effective surgical adjuvant therapy for high-risk rectal carcinoma. N Engl J Med 1991; 324: 709-715.
    • (1991) N Engl J Med , vol.324 , pp. 709-715
    • Krook, J.E.1    Moertel, C.G.2    Gunderson, L.L.3
  • 46
    • 0030805013 scopus 로고    scopus 로고
    • Randomized control trial of postoperative radiotherapy and short-term scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer, Norwegian Adjuvant Rectal Cancer Group
    • Tveit KM, Guldvog I, Hagen S. Randomized control trial of postoperative radiotherapy and short-term scheduled 5-fluorouracil against surgery alone in the treatment of Dukes B and C rectal cancer, Norwegian Adjuvant Rectal Cancer Group. Br J Surg 1997; 84: 1130-1135.
    • (1997) Br J Surg , vol.84 , pp. 1130-1135
    • Tveit, K.M.1    Guldvog, I.2    Hagen, S.3
  • 47
    • 0035922657 scopus 로고    scopus 로고
    • Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials
    • Colorectal Cancer Collaborative Group
    • Colorectal Cancer Collaborative Group. Adjuvant radiotherapy for rectal cancer: A systematic overview of 8,507 patients from 22 randomised trials. Lancet 2001; 358: 1291-1304.
    • (2001) Lancet , vol.358 , pp. 1291-1304
  • 48
    • 33745698661 scopus 로고    scopus 로고
    • Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision wfth selective lateral pelvic lymphadenectomy: A multicenter randomized controlled trial
    • Akasu T, Moriya Y, Ohashi Y et al. Adjuvant chemotherapy with uracil-tegafur for pathological stage III rectal cancer after mesorectal excision wfth selective lateral pelvic lymphadenectomy: A multicenter randomized controlled trial. Jpn J Clin Oncol 2006; 36: 237-244.
    • (2006) Jpn J Clin Oncol , vol.36 , pp. 237-244
    • Akasu, T.1    Moriya, Y.2    Ohashi, Y.3
  • 49
    • 0030833057 scopus 로고    scopus 로고
    • Postoperative adjuvant chemotherapy with miltomycin C and UFT for rectal cancer
    • Kodaira S. Postoperative adjuvant chemotherapy with miltomycin C and UFT for rectal cancer. Oncology (Huntingt) 1997; 11 (9 Suppl 10): 40-43.
    • (1997) Oncology (Huntingt) , vol.11 , Issue.9 SUPPL. 10 , pp. 40-43
    • Kodaira, S.1
  • 50
    • 34247182068 scopus 로고    scopus 로고
    • An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer
    • Sakamoto J, Hamada C, Yoshida S et al. An individual patient data meta-analysis of adjuvant therapy with uracil-tegafur (UFT) in patients with curatively resected rectal cancer. Br J Cancer 2007; 96: 1170-1177.
    • (2007) Br J Cancer , vol.96 , pp. 1170-1177
    • Sakamoto, J.1    Hamada, C.2    Yoshida, S.3
  • 51
    • 0037348549 scopus 로고    scopus 로고
    • Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients
    • Millward MJ, Boyer MJ, Lehnert M et al. Docetaxel and carboplatin is an active regimen in advanced non-small-cell lung cancer: A phase II study in Caucasian and Asian patients, Ann Oncol 2003; 14: 449-454.
    • (2003) Ann Oncol , vol.14 , pp. 449-454
    • Millward, M.J.1    Boyer, M.J.2    Lehnert, M.3
  • 52
    • 4444243813 scopus 로고    scopus 로고
    • Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United States and Japan study of UFT/LV
    • Shirao K, Hoff PM, Ohtsu A et al. Comparison of the efficacy, toxicity, and pharmacokinetics of a uracil/tegafur (UFT) plus oral leucovorin (LV) regimen between Japanese and American patients with advanced colorectal cancer: Joint United States and Japan study of UFT/LV. J Clin Oncol 2004; 22: 3466-3474.
    • (2004) J Clin Oncol , vol.22 , pp. 3466-3474
    • Shirao, K.1    Hoff, P.M.2    Ohtsu, A.3
  • 53
    • 33750716502 scopus 로고    scopus 로고
    • Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer
    • Hsieh CH, Chen YJ, Chang KH et al. Post-operative concurrent chemoradiation therapy using oral uracil-tegafur versus weekly intravenous fluorouracil for locally advanced rectal cancer. Anticancer Res 2006; 26: 3709-3715.
    • (2006) Anticancer Res , vol.26 , pp. 3709-3715
    • Hsieh, C.H.1    Chen, Y.J.2    Chang, K.H.3
  • 54
    • 34447131751 scopus 로고    scopus 로고
    • Concomitant administration of uraciltegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer
    • Atasoy BM, Abacioglu U, Ozgen Z et al. Concomitant administration of uraciltegafur and leucovorin during adjuvant radiotherapy for locally advanced rectal cancer. J BUON 2007; 12: 203-208.
    • (2007) J BUON , vol.12 , pp. 203-208
    • Atasoy, B.M.1    Abacioglu, U.2    Ozgen, Z.3
  • 55
    • 33644664586 scopus 로고    scopus 로고
    • The integraton of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: How successful have we been?
    • Glynne-Jones R, Dunst J, Sebag-Montefiore D. The integraton of oral capecitabine into chemoradiation regimens for locally advanced rectal cancer: How successful have we been? Ann Oncol 2006; 17: 361-371.
    • (2006) Ann Oncol , vol.17 , pp. 361-371
    • Glynne-Jones, R.1    Dunst, J.2    Sebag-Montefiore, D.3
  • 56
    • 0344109583 scopus 로고    scopus 로고
    • Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer
    • Meta-analysis Group In Cancer
    • Meta-analysis Group In Cancer. Efficacy of intravenous continuous infusion of fluorouracil compared with bolus administration in advanced colorectal cancer. J mClin Oncol 1998; 16: 301-308.
    • (1998) J mClin Oncol , vol.16 , pp. 301-308
  • 57
    • 37349040121 scopus 로고    scopus 로고
    • Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review
    • Saif MW, Hashmi S, Zelterman D et al. Capecitabine vs continuous infusion 5-FU in neoadjuvant treatment of rectal cancer. A retrospective review. Int J Colorectal Dis 2008; 23: 139-145.
    • (2008) Int J Colorectal Dis , vol.23 , pp. 139-145
    • Saif, M.W.1    Hashmi, S.2    Zelterman, D.3
  • 58
    • 48749131886 scopus 로고    scopus 로고
    • UFT Summary of Product Characteristics. http://emc.medicines.org.uk/emc/ assets/c/html/DisplayDoc.asp?DocurrientD=4399 (2 August 2007, date last accessed).
    • UFT Summary of Product Characteristics. http://emc.medicines.org.uk/emc/ assets/c/html/DisplayDoc.asp?DocurrientD=4399 (2 August 2007, date last accessed).
  • 59
    • 40749087276 scopus 로고    scopus 로고
    • Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines?
    • Yen-Revollo JL, Goldberg RM, McLeod HL. Can inhibiting dihydropyrimidine dehydrogenase limit hand-foot syndrome caused by fluoropyrimidines? Clin Cancer Res 2008; 14: 8-13.
    • (2008) Clin Cancer Res , vol.14 , pp. 8-13
    • Yen-Revollo, J.L.1    Goldberg, R.M.2    McLeod, H.L.3
  • 60
    • 33144459846 scopus 로고    scopus 로고
    • Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer
    • Kim JS, Kim JS, Cho MJ et al. Comparison of the efficacy of oral capecitabine versus bolus 5-FU in preoperative radiotherapy of locally advanced rectal cancer. J Korean Med Sci 2006; 21: 52-57.
    • (2006) J Korean Med Sci , vol.21 , pp. 52-57
    • Kim, J.S.1    Kim, J.S.2    Cho, M.J.3
  • 61
    • 33846229229 scopus 로고    scopus 로고
    • Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer
    • Kim DY, Jung KH et al. Comparison of 5-fluorouracil/leucovorin and capecitabine in preoperative chemoradiotherapy for locally advanced rectal cancer: Int J Radiat Oncol Biol Phys 2007; 67: 378-384.
    • (2007) Int J Radiat Oncol Biol Phys , vol.67 , pp. 378-384
    • Kim, D.Y.1    Jung, K.H.2
  • 62
    • 33751179691 scopus 로고    scopus 로고
    • Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis
    • Das P, Lin EH, Bhatia S et al. Preoperative chemoradiotherapy with capecitabine versus protracted infusion 5-fluorouracil for rectal cancer: A matched-pair analysis, Int J Radiat Oncol Biol Phys 2006; 66: 1378-1383.
    • (2006) Int J Radiat Oncol Biol Phys , vol.66 , pp. 1378-1383
    • Das, P.1    Lin, E.H.2    Bhatia, S.3
  • 63
    • 0034162884 scopus 로고    scopus 로고
    • Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02
    • Wolmark N, Wieand HS, Hyams DM et al. Randomized trial of postoperative adjuvant chemotherapy with or without radiotherapy for carcinoma of the rectum: National Surgical Adjuvant Breast and Bowel Project Protocol R-02. J Natl Cancer Inst 2000; 92: 388-396.
    • (2000) J Natl Cancer Inst , vol.92 , pp. 388-396
    • Wolmark, N.1    Wieand, H.S.2    Hyams, D.M.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.